Cybiocare is currently developing photonics-based products to accurately measure a full range of clinical states including heart beat, blood perfusion, oximetry, hydration and relative glucose trend, as well as tissue temperature and humidity. Cybiocare medical devices are designed for point-of-care testing at home or in research, clinical, hospital and even sports settings.

The world’s first Optical Hypoglycemia Detector (OHD)
Cybiocare is proud to introduce the world’s first Optical Hypoglycemia Detector (OHD), now in full prototype and testing stage. The Cybiocare OHD is designed as a totally non-invasive way to help prevent hypoglycemia among the millions of people with diabetes today.

Portable wearable device for permanent monitoring
The wearable, watch-size Cybiocare OHD warns diabetics when blood glucose drops below a certain critical level. The OHD is designed to be used in conjunction with existing blood glucose meters to provide permanent monitoring. The OHD will ensure peace of mind for millions of diabetics around the world, making it easier for them to lead normal lives instead of having to constantly focus on their disease.

Key benefits of the Cybiocare Optical Hypoglycemia Detector:

• Beeper alarm at hypoglycemia onset
  
  
• Truly non-invasive to allow maximum freedom and mobility
  
  
• Dynamic auto calibration better adapts to individual needs
  
  
• Portable design operates on simple battery power
  for extended periods of time
  
  
• Complements existing glucose meters
  
  
• Detects hypoglycemia better than other non-invasive products because it tracks the glucose trend…and that means far fewer false alarms